
Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk
The FDA approved olezarsen (Tryngolza) to reduce triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyceridemia, the agency announced on Wednesday. Olezarsen, an mRNA-targeted antisense ol...


